Dimension Therapeutics
Latest round
- Series B
Last raised
- Apr 2015
Total raised
- $90M
Investors
- 7
About Dimension Therapeutics
Dimension Therapeutics Inc, founded in 2013 in Cambridge, US, specializes in gene therapy products targeting rare diseases.5 mn.Dimension Therapeutics focuses on delivering innovative gene therapies, targeting genetic disorders through advanced biotechnological solutions.47 mn.Dimension Therapeutics aims to expand its product offerings with the development of new gene therapies targeting additional rare diseases expected to enter clinical trials by 2024.
Who invested in Dimension Therapeutics
7 investors across 3 rounds
See all investors in Dimension Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Dimension Therapeutics
Who invested in Dimension Therapeutics?
Dimension Therapeutics has 7 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Dimension Therapeutics raised?
Dimension Therapeutics has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Dimension Therapeutics last raise money?
Dimension Therapeutics's most recent round on record is a Series B, in Apr 2015.
What does Dimension Therapeutics do?
Dimension Therapeutics Inc, founded in 2013 in Cambridge, US, specializes in gene therapy products targeting rare diseases.
Where is Dimension Therapeutics headquartered?
Dimension Therapeutics is headquartered in Cambridge, US.
Which VCs invest in companies like Dimension Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Dimension Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Dimension Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.